Jump to section
To drive lower prescription costs and improve transparency throughout the pharmaceutical supply chain, connecting patients to prescription drugs where and when they need them.
-2% employee growth in 12 months
The current landscape of the prescription drug industry is complex and increasingly unaffordable. Truveris designs data-driven solutions to provide transparency, affordability, and accessibility to the $300 Billion drug prescription market in the US.
The startup stands out in the prescription drug ecosystem by offering clients cloud-data services, insights, and management tools to help combat the rising costs within the industry. The software allows pharmacists, drug brokers and life science companies to access pharmaceutical prices, research and data.
Truveris already analyzes a good portion of all prescriptions in the US. This has been achieved by providing solutions to pharmacy plans, pricing and reporting. Furthermore, the company's use of cloud technology and predictive analysis shows great promise in changing the future landscape of digital pharmacies.
Steph
Company Specialist at Welcome to the Jungle
May 2024
$15m
SERIES E
Sep 2017
$25m
SERIES D
This company has top investors
Nanette Oddo
(President & CEO, not founder)Started at the company in 2019 as the CSO before being promoted to her current position in 2021. Former President of Dimension Associates and General Manager/VP of Phreesia.